Are OKUR insiders buying or selling?

Over the last 90 days, OKUR insiders were net sellers, reporting $0.00 of open-market purchases and $1,157 of sales.

When was the last OKUR insider purchase?

No open-market insider purchase of OnKure Therapeutics, Inc. stock was reported in the last 90 days.

Where does OKUR insider trading data come from?

Watch Insiders reads the SEC Form 4 filings that OnKure Therapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.

OKURSector not reported

OnKure Therapeutics, Inc. (OKUR) Insider Trading

In the last 90 days, 2 OnKure Therapeutics, Inc. (OKUR) insiders reported no open-market purchases and 2 sales totaling $1,157. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers: 0
90-day purchase value: $0.00
Corporate buyers: 0
Latest transaction: Sep 21, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
Date	Insider name	Role	Type	Shares	Price	Total value
Sep 21, 2026	Jason A. Leverone	Chief Financial Officer	Sale	302	$2.97	$898.21
Sep 21, 2026	Nicholas A Saccomano	President and CEO	Sale	87	$2.97	$258.76
Jun 22, 2026	Jason A. Leverone	Chief Financial Officer	Sale	303	$4.40	$1,332
Jun 22, 2026	Nicholas A Saccomano	President and CEO	Sale	86	$4.40	$378.08

Common questions

OKUR insider trading FAQ

Are OKUR insiders buying or selling?: Over the last 90 days, OKUR insiders were net sellers, reporting $0.00 of open-market purchases and $1,157 of sales.
When was the last OKUR insider purchase?: No open-market insider purchase of OnKure Therapeutics, Inc. stock was reported in the last 90 days.
Where does OKUR insider trading data come from?: Watch Insiders reads the SEC Form 4 filings that OnKure Therapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.